Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jian-Yu Weng"'
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 3, Pp 194-199 (2024)
Externí odkaz:
https://doaj.org/article/29880527871042368296cbc2d9822729
Publikováno v:
Turkish Journal of Hematology; Sep2024, Vol. 41 Issue 3, p194-199, 6p
Publikováno v:
Clinical and Translational Oncology. 25:1805-1820
Autor:
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, Xin Du, Chun‐yan Chen, Jian‐yu Weng, Jian Huang, Fei Li, Yun Zeng, Zhen Xiao, Jian‐da Hu, Li‐jie Yang, Zhuo‐gang Liu, Guo‐hui Li, Xiu‐li Sun, Wei Yang, Ru Feng, Yan‐qiu Han, Yu Jing, Na Xu, Xiao‐li Liu, Zhen‐fang Liu, Xiao‐dong Wang, Shi‐xin Wu, Rong Liang, Yan‐li Zhang, Yun‐fan Yang, Huan‐ling Zhu, Ling Pan, Li Meng, Yan‐hong Zhao, Hai Yi, Yi‐lan Liu, Wei‐hua Zhang, Yuan‐jun Zheng, Ze‐ping Zhou, Su‐ning Chen, Hui‐ying Qiu, Wei‐ming Li, Zhi‐lin Jia, Yan‐liang Bai, Li‐e Lin, Bing‐cheng Liu, Chun‐shui Liu, Jian‐min Luo, Jun‐xia Meng, Zhi‐qiang Sun, Yan‐qing Zhang, Xiao‐jun Huang, Qian Jiang
Publikováno v:
American Journal of Hematology.
Autor:
Jun-Dan, Wang, Jue-Qiong, Xu, Xue-Ning, Zhang, Ze-Wei, Huang, Ling-Ling, Liu, Ling, Zhang, Xin-Xing, Lei, Man-Jie, Xue, Jian-Yu, Weng, Zi-Jie, Long
Publikováno v:
Cell proliferation. 55(12)
Mutant C/EBPα p30 (mp30), the product of C/EBPα double mutations (DM), lacks transactivation domain 1 and has C-terminal loss-of-function mutation. Acute myeloid leukaemia (AML) patients harbouring C/EBPα DM could be classified as a distinct subgr
Autor:
Jun-Dan Wang, Fu-Xin Huang, Ling Zhang, Xin-Xing Lei, Jue-Qiong Xu, Jian-Yu Weng, Zi-Jie Long
Publikováno v:
SSRN Electronic Journal.
Autor:
Ya-Qin, Jiang, Na, Xu, Xiao-Li, Liu, Ji-Shi, Wang, Zhong, Yuan, Ji-Xian, Huang, Jian-Yu, Weng, Shu-Yun, Cao, Shi-Shan, Xiao, Hong-Qian, Zhu
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 29(6)
To observe the curative efficacy of tyrosine kinase inhibitors (TKIs) in the treatment of e19a2 transcript (P230) CML chronic phase (CML-CP) patients.The clinical data of 11 P230 CML-CP patients were collected from July 2008 to December 2019. Blood r
Autor:
Wei-Ya, Zhang, Gao-Chun, Zeng, Xiao-Mei, Chen, Su-Xia, Geng, Yu-Lian, Wang, Qiong, Luo, Liu-Ping, Luo, Pei-Long, Lai, Jian-Yu, Weng, Xin, DU
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 29(5)
To establish the in vivo traceable acute myeloid leukemia mice model with Luciferase-Expressing KG1a Cells.KG1a cells with stable luciferase gene expression (called as KG1a-Luc cells) were constructed by lentivirus transfection, then sifted out by pu
Autor:
Chao, Li, Su-Xia, Geng, Min-Ming, Li, Fang, Su, Xiao-Mei, Chen, Cheng-Xin, Deng, Xin, Huang, Pei-Long, Lai, Jian-Yu, Weng, Xin, DU
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 28(1)
To investigate the expression and significance of B and T lymphocyte weakening factor (BTLA) in patients with chronic myelomonocytic leukemia (CMML).Real-time PCR was used to detect the expression of BTLA and its ligand HVEM mRNA in 11 patients with
Autor:
Yang Gao, Wang Xiaoyan, Hao-Wen Xiao, Jian-Yu Weng, Hai-Jia Chen, Xin Du, Jing-Ren Lin, Yang Xiao, Ge Xiaohu, Danian Nie, Dongjun Lin, Huo Tan, Duorong Xu, Hongbo Li, Zujun Jiang, Li Li, Yan Pang, Zenghui Liu, Hang Zhang, Qifa Liu, Xiang-Zhong Zhang
Publikováno v:
Stem Cells Translational Medicine. 6:1569-1575
We conducted a phase II, noncomparative, multicenter study to assess the efficacy and safety of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) expanded in vitro for patients with aplastic anemia (AA) refractory to immunosuppressiv